Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation

Pharmaceutical Research

Volumn 23, Issue 11, 2006, Pages 2556-2565

  Adi, Handoko ^a   Larson, Ian ^a   Chiou, Herbert ^b   Young, Paul ^b   Traini, Daniela ^b   Stewart, Peter ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Agglomeration; Drug dispersion; Dry powder inhalation; Fine lactose; Interactive mixture; Salmeterol xinafoate

Indexed keywords

LACTOSE PERMEASE; SALMETEROL XINAFOATE;

AEROSOL; ANALYTIC METHOD; ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; DRUG CARRIERS; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS;

EID: 33750631018     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9082-6     Document Type: Article

References (15)

1. N. Islam, P. J. Stewart, I. Larson, and P. Hartley. Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures. J. Pharm. Sci. 93:1030-1038 (2004).
2. M. D. Louey, S. Razia, and P. J. Stewart. Influence of physicochemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int. J. Pharm. 252:87-98 (2003).
3. X. M. Zeng, G. P. Martin, S.-K. Tee, and C. Marriott. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int. J. Pharm. 176:99-110 (1998).
4. P. Lucas, K. Anderson, and J. N. Staniforth. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 15:562-569 (1998).
5. L. A. Mackin, G. Rowley, and E. F. Fletcher. An investigation of carrier particle type, electrostatic charge and relative humidity on in vitro drug deposition from dry powder inhaler formulations. Pharm. Sci. 3:583-586 (1997).
6. X. M. Zeng, K. H. Pandhal, and G. P. Martin. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int. J. Pharm. 197:41-52 (2000).
7. M. D. Louey and P. J. Stewart. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 19:1524-1531 (2002).
8. D. Ganderton. The generation of respirable cloud from coarse powder aggregates. J. Biopharm. Sci. 3:101-105 (1992).
9. M. A. Braun, R. Oschmann, and P. C. Schmidt. Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger. Int. J. Pharm. 135:53-62 (1996).
10. T. Srichana, G. P. Martin, and C. Marriott. On the relationship between drug and carrier deposition from dry powder inhalers in vitro. Int. J. Pharm. 167:13-23 (1998).
11. H. Adi, I. Larson, and P. J. Stewart. Fractionation of narrow particle size distributions of micronised lactose by milking and wet seiving techniques. CHEMECA, Australasian Chemical Engineering, Brisbane, Australia, 2005.
12. H. Adi, I. Larson, and P. J. Stewart. Influence of cohesive properties of micronised lactose powders on particle size analysis by laser diffraction. CHEMECA, Australasian Chemical Engineering, Brisbane, Australia, 2005.
13. B. Alway, R. Sangchantra, and P. J. Stewart. Modelling the dissolution of diazepam in lactose interactive mixtures. Int. J. Pharm. 130:213-224 (1996).
14. N. Islam, P. J. Stewart, I. Larson, and P. Hartley. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm. Res. 21:492-499 (2004).
15. K. Kendall and C. Stainton. Adhesion and aggregation of fine particles. Powder Technol. 121:223-229 (2001).